Merck | MRK - Operating Expenses

Stock Price
128.15
Daily Change
0.25 0.20%
Monthly
-0.19%
Yearly
-6.60%
Q1 Forecast
123.95

Merck reported EUR4.11B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Adidas EUR 5.89B 489M Sep/2025
Adyen EUR 766.45M 83.9M Jun/2025
Akzo Nobel EUR 2.16B 95M Dec/2025
Alcon AG USD 2.28B 67M Sep/2025
Amadeus IT EUR 1.15B 20.2M Sep/2025
Amarin USD 51.37M 14.6M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 13.84B 1.11B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Beiersdorf EUR 4.37B 143M Jun/2025
Covestro EUR -2.22B 5.55B Sep/2025
Danone EUR 11.92B 131M Jun/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Henkel EUR 8.79B 444M Jun/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Infineon EUR 3.27B 131M Dec/2025
Linde USD 6.21B 52M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024